# OnCo record nct07593144 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct07593144/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct07593144", "NCT07593144" ;
  schema:name "A Single-Arm, Open-Label Phase Ia/Ib Clinical Trial Evaluating the Safety, Tolerability, Pharmacokinetic Profile, and Preliminary Efficacy of FS-207 in Patients With Advanced Solid Tumors With High Microsatellite Instability (MSI-H)"@en ;
  schema:description "A phase 1 trial of FS-207 run by Foresight Therapeutics (Hefei) Co., Ltd., not yet recruiting."@en ;
  schema:url <https://onco.cc/trials/nct07593144/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT07593144> ;
  onco:status "planned" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "1" ;
  onco:cancers <https://onco.cc/cancers/metastatic-cancer/> ;
  onco:drugs <https://onco.cc/drugs/fs-207/> ;
  onco:companies <https://onco.cc/companies/fushi-biotechnology/> .